Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Rodewisch

5 clinical trials in Rodewisch, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Rodewisch at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Rodewisch

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Rodewisch

What the registry says about research in the country

01 Triple-Negative Breast Cancer Research

Innovative clinical trials exploring the combination of chemotherapy and immunotherapy for patients with triple-negative breast cancer, focusing on improving treatment outcomes through targeted therapeutic approaches.

  • Neoadjuvant chemotherapy evaluation
  • Immunotherapy integration
  • Event-free survival assessment

Research aims to enhance treatment effectiveness through combination therapy strategies.

02 HR+/HER2- Breast Cancer Studies

Groundbreaking research comparing endocrine therapy combined with targeted treatments versus standard chemotherapy for intermediate-risk breast cancer patients.

  • Personalized therapy approaches
  • Disease-free survival analysis
  • Treatment optimization strategies

Studies focus on developing more effective, personalized treatment options with improved survival outcomes.

03 HER2-Related Breast Cancer Trials

Advanced clinical research evaluating novel targeted therapies for both HER2-negative and HER2-positive breast cancer, including innovative drug combinations and treatment approaches.

  • Treatment response assessment
  • Pathologic complete response evaluation
  • Long-term survival monitoring

These trials aim to establish more effective treatment protocols for specific breast cancer subtypes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.